BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kabir S. The current status of Helicobacter pylori vaccines: a review. Helicobacter. 2007;12:89-102. [PMID: 17309745 DOI: 10.1111/j.1523-5378.2007.00478.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Kabir S. Effect of Helicobacter pylori eradication on incidence of gastric cancer in human and animal models: underlying biochemical and molecular events. Helicobacter. 2009;14:159-171. [PMID: 19702845 DOI: 10.1111/j.1523-5378.2009.00677.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
2 Wu C, Shi Y, Guo H, Zou W, Guo G, Xie Q, Mao X, Tong W, Zou Q. Protection Against Helicobacter pylori Infection in Mongolian Gerbil by Intragastric or Intramuscular Administration of H. pylori Multicomponent Vaccine: Protection with H. pylori Multicomponent Vaccine. Helicobacter 2008;13:191-9. [DOI: 10.1111/j.1523-5378.2008.00609.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
3 Kabir S. The role of interleukin-17 in the Helicobacter pylori induced infection and immunity. Helicobacter. 2011;16:1-8. [PMID: 21241406 DOI: 10.1111/j.1523-5378.2010.00812.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 5.1] [Reference Citation Analysis]
4 Mandeville KL, Krabshuis J, Ladep NG, Mulder CJ, Quigley EM, Khan SA. Gastroenterology in developing countries: Issues and advances. World J Gastroenterol 2009; 15(23): 2839-2854 [PMID: 19533805 DOI: 10.3748/wjg.15.2839] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 51] [Article Influence: 3.7] [Reference Citation Analysis]
5 Vítor JM, Vale FF. Alternative therapies for Helicobacter pylori: probiotics and phytomedicine. FEMS Immunol Med Microbiol. 2011;63:153-164. [PMID: 22077218 DOI: 10.1111/j.1574-695x.2011.00865.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
6 de Vries R, Klok RM, Brouwers JR, Postma MJ. Cost-effectiveness of a potential future Helicobacter pylori vaccine in the Netherlands: the impact of varying the discount rate for health. Vaccine 2009;27:846-52. [PMID: 19084566 DOI: 10.1016/j.vaccine.2008.11.081] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
7 Jagusztyn-krynicka EK, Dadlez M, Grabowska A, Roszczenko P. Proteomic technology in the design of new effective antibacterial vaccines. Expert Review of Proteomics 2014;6:315-30. [DOI: 10.1586/epr.09.47] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
8 Ingolotti M, Kawalekar O, Shedlock DJ, Muthumani K, Weiner DB. DNA vaccines for targeting bacterial infections. Expert Rev Vaccines 2010;9:747-63. [PMID: 20624048 DOI: 10.1586/erv.10.57] [Cited by in Crossref: 83] [Cited by in F6Publishing: 65] [Article Influence: 6.9] [Reference Citation Analysis]
9 Iankov ID, Haralambieva IH, Galanis E. Immunogenicity of attenuated measles virus engineered to express Helicobacter pylori neutrophil-activating protein. Vaccine. 2011;29:1710-1720. [PMID: 21182995 DOI: 10.1016/j.vaccine.2010.12.020] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
10 Malekshahi ZV, Gargari SL, Rasooli I, Ebrahimizadeh W. Treatment of Helicobacter pylori infection in mice with oral administration of egg yolk-driven anti-UreC immunoglobulin. Microb Pathog 2011;51:366-72. [PMID: 21803146 DOI: 10.1016/j.micpath.2011.06.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
11 Cen Q, Gao T, Ren Y, Lu X, Lei H. Immune evaluation of a Saccharomyces cerevisiae-based oral vaccine against Helicobacter pylori in mice. Helicobacter 2021;26:e12772. [PMID: 33219579 DOI: 10.1111/hel.12772] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Zhang YY, Xia HH, Zhuang ZH, Zhong J. Review article: 'true' re-infection of Helicobacter pylori after successful eradication--worldwide annual rates, risk factors and clinical implications. Aliment Pharmacol Ther 2009;29:145-60. [PMID: 18945250 DOI: 10.1111/j.1365-2036.2008.03873.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
13 Aebischer T, Walduck A, Schroeder J, Wehrens A, Chijioke O, Schreiber S, Meyer TF. A vaccine against Helicobacter pylori: towards understanding the mechanism of protection. Int J Med Microbiol 2008;298:161-8. [PMID: 17702653 DOI: 10.1016/j.ijmm.2007.07.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
14 Hill RA, Flint DJ, Pell JM. Antibodies as molecular mimics of biomolecules: roles in understanding physiological functions and mechanisms. Advances in Physiology Education 2008;32:261-73. [DOI: 10.1152/advan.90130.2008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
15 [DOI: 10.1101/198796] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Moujaber T, MacIntyre CR, Backhouse J, Gidding H, Quinn H, Gilbert GL. The seroepidemiology of Helicobacter pylori infection in Australia. Int J Infect Dis 2008;12:500-4. [PMID: 18400542 DOI: 10.1016/j.ijid.2008.01.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
17 Borlace GN, Keep SJ, Prodoehl MJR, Jones HF, Butler RN, Brooks DA. A role for altered phagosome maturation in the long-term persistence of Helicobacter pylori infection. American Journal of Physiology-Gastrointestinal and Liver Physiology 2012;303:G169-79. [DOI: 10.1152/ajpgi.00320.2011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
18 Anderl F, Gerhard M. Helicobacter pylori vaccination: Is there a path to protection? World J Gastroenterol 2014; 20(34): 11939-11949 [PMID: 25232229 DOI: 10.3748/wjg.v20.i34.11939] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
19 Ameri Shah Reza M, Mousavi Gargari SL, Rasooli I, Jalali Nadoushan M, Ebrahimizadeh W. Inhibition of H. pylori colonization and prevention of gastritis in murine model. World J Microbiol Biotechnol 2012;28:2513-9. [PMID: 22806157 DOI: 10.1007/s11274-012-1059-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Lahner E, Bernardini G, Santucci A, Annibale B. Helicobacter pylori immunoproteomics in gastric cancer and gastritis of the carcinoma phenotype. Expert Rev Proteomics. 2010;7:239-248. [PMID: 20377390 DOI: 10.1586/epr.10.5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
21 Xie JH, Chen YL, Wu QH, Wu J, Su JY, Cao HY, Li YC, Li YS, Liao JB, Lai XP. Gastroprotective and anti-Helicobacter pylori potential of herbal formula HZJW: safety and efficacy assessment. BMC Complement Altern Med. 2013;13:119. [PMID: 23721522 DOI: 10.1186/1472-6882-13-119] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
22 Yokoyama H, Tsuruta O, Akao N, Fujii S. Crystal structure of Helicobacter pylori neutrophil-activating protein with a di-nuclear ferroxidase center in a zinc or cadmium-bound form. Biochem Biophys Res Commun 2012;422:745-50. [PMID: 22618234 DOI: 10.1016/j.bbrc.2012.05.073] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
23 Attallah AM, Abbas AT, Ismail H, Abdel-Raouf M, El-Dosoky I. Efficacy of passive immunization with IgY antibodies to a 58-kDa H. pylori antigen on severe gastritis in BALB/c mouse model. J Immunoassay Immunochem 2009;30:359-77. [PMID: 19739011 DOI: 10.1080/15321810903187922] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zhao W, Wu W, Xu X. Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice. Vaccine 2007;25:7664-73. [PMID: 17913305 DOI: 10.1016/j.vaccine.2007.08.034] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
25 Flach C, Svensson N, Blomquist M, Ekman A, Raghavan S, Holmgren J. A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori. Vaccine 2011;29:1235-41. [DOI: 10.1016/j.vaccine.2010.11.088] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
26 Bernardini G, Braconi D, Lusini P, Santucci A. Helicobacter pylori : immunoproteomics related to different pathologies. Expert Review of Proteomics 2014;4:679-89. [DOI: 10.1586/14789450.4.5.679] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
27 Yokoyama H, Fujii S. Structures and metal-binding properties of Helicobacter pylori neutrophil-activating protein with a di-nuclear ferroxidase center. Biomolecules 2014;4:600-15. [PMID: 24971723 DOI: 10.3390/biom4030600] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
28 Malshe P. Drinking air and manoeuvering it to the pyloric region of the stomach for the treatment for Helicobacter pylori infection. Medical Hypotheses 2010;75:155-61. [DOI: 10.1016/j.mehy.2010.02.010] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Napolitano L. Refractory Peptic Ulcer Disease. Gastroenterology Clinics of North America 2009;38:267-88. [DOI: 10.1016/j.gtc.2009.03.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
30 Wang L, Liu XF, Yun S, Yuan XP, Mao XH, Wu C, Zhang WJ, Liu KY, Guo G, Lu DS. Protection against Helicobacter pylori infection by a trivalent fusion vaccine based on a fragment of urease B-UreB414. J Microbiol. 2010;48:223-228. [PMID: 20437155 DOI: 10.1007/s12275-009-0233-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
31 Ruggiero P, Censini S. Helicobacter pylori: A Brief History of a Still Lacking Vaccine. Diseases 2014;2:187-208. [DOI: 10.3390/diseases2020187] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
32 Pan XZ, Peng XW, Peng RJ. Antibiotic resistance of Helicobacter pyloriShijie Huaren Xiaohua Zazhi 2008; 16(8): 806-813 [DOI: 10.11569/wcjd.v16.i8.806] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
33 Fock KM, Graham DY, Malfertheiner P. Helicobacter pylori research: historical insights and future directions. Nat Rev Gastroenterol Hepatol. 2013;10:495-500. [PMID: 23752823 DOI: 10.1038/nrgastro.2013.96] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 8.2] [Reference Citation Analysis]
34 Kenny LC, Kell DB. Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father. Front Med (Lausanne) 2017;4:239. [PMID: 29354635 DOI: 10.3389/fmed.2017.00239] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
35 Zarei M, Mosayebi G, Khansarinejad B, Abtahi H. Antigenic and immunogenic evaluation of Helicobacter pylori FlaA epitopes. Iran J Basic Med Sci 2017;20:920-6. [PMID: 29085584 DOI: 10.22038/IJBMS.2017.9115] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Salih BA. Helicobacter pylori infection in developing countries: the burden for how long? Saudi J Gastroenterol. 2009;15:201-207. [PMID: 19636185 DOI: 10.4103/1319-3767.54743] [Cited by in Crossref: 73] [Cited by in F6Publishing: 71] [Article Influence: 5.6] [Reference Citation Analysis]
37 Chen J, Li N, She F. Helicobacter pylori outer inflammatory protein DNA vaccine-loaded bacterial ghost enhances immune protective efficacy in C57BL/6 mice. Vaccine. 2014;32:6054-6060. [PMID: 25236588 DOI: 10.1016/j.vaccine.2014.09.014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
38 Mirzaei N, Poursina F, Moghim S, Rashidi N, Ghasemian Safaei H. The study of H. pylori putative candidate factors for single- and multi-component vaccine development. Crit Rev Microbiol 2017;43:631-50. [PMID: 28581361 DOI: 10.1080/1040841X.2017.1291578] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
39 Zhao SG, Wang JQ, Liu GL, Cheng JB, Zhang CG. Culture of Helicobacter pylori and purification of antigen protein. Shijie Huaren Xiaohua Zazhi 2008; 16(10): 1098-1104 [DOI: 10.11569/wcjd.v16.i10.1098] [Reference Citation Analysis]
40 Keep S, Borlace G, Butler R, Brooks D. Role of immune serum in the killing of Helicobacter pylori by macrophages. Helicobacter. 2010;15:177-183. [PMID: 20557358 DOI: 10.1111/j.1523-5378.2010.00750.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
41 Ayala G, Escobedo-Hinojosa WI, Cruz-Herrera CFL, Romero I. Exploring alternative treatments for Helicobacter pylori infection. World J Gastroenterol 2014; 20(6): 1450-1469 [PMID: 24587621 DOI: 10.3748/wjg.v20.i6.1450] [Cited by in CrossRef: 77] [Cited by in F6Publishing: 64] [Article Influence: 9.6] [Reference Citation Analysis]
42 Mony TJ, Kwon H, Won M, Kang Y, Lee S, Kim S, Baek D, Elahi F. Anti-urease immunoglobulin (IgY) from egg yolk prevents Helicobacter pylori infection in a mouse model. Food and Agricultural Immunology 2019;30:662-76. [DOI: 10.1080/09540105.2019.1617251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]